Androgen receptor (AR) gene (CAG)n and (GGN)n length polymorphisms and symptoms in young males with long-lasting adverse effects after finasteride use against androgenic alopecia

    March 2017 in “European Urology Supplements
    Giovanni Chiriaco, Sabina Cauci, Emanuela Cecchin, Giuseppe Toffoli, Serena Xodo, Giuseppe Stinco, Carlo Trombetta
    Image of study
    TLDR Gene differences affect finasteride side effects in men with hair loss.
    The study explored whether certain gene polymorphisms in the androgen receptor (AR) gene are implicated in Post-Finasteride Syndrome (PFS), which are long-term adverse symptoms experienced by men who used finasteride as an oral drug against androgenic alopecia (AGA). The study found that the short and/or long (CAG)n and (GGN)n repeats had different frequencies according to symptoms experienced by PFS patients, likely reflecting the vast array of genes modulated by the AR. The study also found a U-curvilinear profile of (CAG)n repeats for skin dryness symptom, where both extremes had a worse condition than medium repeats. Further studies are needed to investigate the PFS pathophysiology using a precision medicine approach.
    View this study on air.uniud.it →

    Related